Inogen To Present at 24th Annual Needham Virtual Healthcare Conference
Inogen (Nasdaq: INGN), a medical technology company specializing in innovative respiratory products for homecare, has announced its participation in the 24th Annual Needham Virtual Healthcare Conference.
The company's leadership team, including President and CEO Kevin Smith and CFO Michael Bourque, will engage in a fireside chat scheduled for Tuesday, April 8, 2025, at 8:45 a.m. Eastern Time.
Interested parties can access both the live audio webcast and archived recording of the presentation through the News / Events section of Inogen's Investor Relations website. The company continues to utilize its Investor Relations website as a platform for disclosing material non-public information and maintaining compliance with Regulation FD.
Inogen (Nasdaq: INGN), un'azienda di tecnologia medica specializzata in prodotti respiratori innovativi per la cura a domicilio, ha annunciato la sua partecipazione alla 24ª Conferenza Virtuale Annuale di Needham sulla Salute.
Il team dirigenziale dell'azienda, compresi il Presidente e CEO Kevin Smith e il CFO Michael Bourque, parteciperà a una chiacchierata informale programmata per martedì 8 aprile 2025, alle 8:45 ora orientale.
Le parti interessate possono accedere sia alla trasmissione audio in diretta che alla registrazione archiviata della presentazione attraverso la sezione News / Eventi del sito web delle Relazioni con gli Investitori di Inogen. L'azienda continua a utilizzare il suo sito web delle Relazioni con gli Investitori come piattaforma per divulgare informazioni materiali non pubbliche e mantenere la conformità con il Regolamento FD.
Inogen (Nasdaq: INGN), una empresa de tecnología médica especializada en productos respiratorios innovadores para el cuidado en el hogar, ha anunciado su participación en la 24ª Conferencia Virtual Anual de Salud de Needham.
El equipo directivo de la empresa, que incluye a el Presidente y CEO Kevin Smith y el CFO Michael Bourque, participará en una charla informal programada para el martes 8 de abril de 2025, a las 8:45 a.m. hora del Este.
Las partes interesadas pueden acceder tanto a la transmisión de audio en vivo como a la grabación archivada de la presentación a través de la sección de Noticias / Eventos del sitio web de Relaciones con Inversores de Inogen. La empresa continúa utilizando su sitio web de Relaciones con Inversores como plataforma para divulgar información material no pública y mantener el cumplimiento con la Regulación FD.
이노겐 (Nasdaq: INGN), 가정용 혁신 호흡기 제품을 전문으로 하는 의료 기술 회사가 제24회 니드햄 가상 헬스케어 컨퍼런스에 참여한다고 발표했습니다.
회사의 경영진, 회장 겸 CEO 케빈 스미스와 CFO 마이클 부르크를 포함하여, 2025년 4월 8일 화요일, 동부 표준시 오전 8시 45분에 예정된 대화에 참여할 것입니다.
관심 있는 분들은 이노겐의 투자자 관계 웹사이트의 뉴스/이벤트 섹션을 통해 라이브 오디오 웹캐스트와 발표의 아카이브 녹음을 모두 이용할 수 있습니다. 이 회사는 투자자 관계 웹사이트를 비공식적인 중요 정보를 공개하고 FD 규정을 준수하는 플랫폼으로 계속 활용하고 있습니다.
Inogen (Nasdaq: INGN), une entreprise de technologie médicale spécialisée dans les produits respiratoires innovants pour les soins à domicile, a annoncé sa participation à la 24e Conférence Virtuelle Annuelle de Needham sur la Santé.
Le comité de direction de l'entreprise, comprenant le Président et CEO Kevin Smith et le CFO Michael Bourque, participera à une discussion informelle prévue pour mardi 8 avril 2025, à 8h45 heure de l'Est.
Les parties intéressées peuvent accéder à la fois à la diffusion audio en direct et à l'enregistrement archivé de la présentation via la section Actualités / Événements du site Web des Relations avec les Investisseurs d'Inogen. L'entreprise continue d'utiliser son site Web des Relations avec les Investisseurs comme plate-forme pour divulguer des informations matérielles non publiques et maintenir sa conformité avec le Règlement FD.
Inogen (Nasdaq: INGN), ein Medizintechnikunternehmen, das sich auf innovative Atemtherapieprodukte für die häusliche Pflege spezialisiert hat, hat seine Teilnahme an der 24. jährlichen virtuellen Needham Healthcare-Konferenz bekannt gegeben.
Das Führungsteam des Unternehmens, einschließlich Präsident und CEO Kevin Smith und CFO Michael Bourque, wird an einem informellen Gespräch teilnehmen, das für Dienstag, den 8. April 2025, um 8:45 Uhr Eastern Time angesetzt ist.
Interessierte Parteien können sowohl auf den Live-Audio-Webcast als auch auf die archivierte Aufnahme der Präsentation über den Bereich Nachrichten / Veranstaltungen der Investor Relations-Website von Inogen zugreifen. Das Unternehmen nutzt weiterhin seine Investor Relations-Website als Plattform zur Offenlegung von wesentlichen nicht-öffentlichen Informationen und zur Einhaltung der Regulation FD.
- None.
- None.
Kevin Smith, President and Chief Executive Officer, and Michael Bourque, Chief Financial Officer, are scheduled to participate in a fireside chat on Tuesday, April 8, 2025, at 8:45 a.m. Eastern Time.
A live audio webcast and archived recording of the presentation will be available to all interested parties through the News / Events page on the Inogen Investor Relations website.
Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.
About Inogen
Inogen, Inc. (Nasdaq: INGN) is a leading global medical technology company offering innovative respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class respiratory therapy devices used to deliver care to patients suffering from chronic respiratory conditions. Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products widely available, allowing patients the chance to manage the impact of their disease.
For more information, please visit www.inogen.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250320728914/en/
Source: Inogen, Inc.
FAQ
When is Inogen (INGN) presenting at the Needham Healthcare Conference 2025?
How can investors watch Inogen's (INGN) Needham Conference presentation?
Which Inogen (INGN) executives are participating in the Needham Healthcare Conference?
What format will Inogen's (INGN) presentation take at the Needham Conference?
Where does Inogen (INGN) disclose its material non-public information?
